or Try an Advanced Search...

    Hepatitis C Virus Infection Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 2.24
    IONS F Ionis Pharmaceuticals, Inc. -2.47
    RGLS F Regulus Therapeutics Inc. 0.64
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis C Virus Infection stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.94
    RDIV A RevenueShares Ultra Dividend Fund 5.39
    PPH D Market Vectors Pharmaceutical ETF 5.02
    MEDX D Horizon Kinetics Medical ETF 4.65
    IHE C iShares U.S. Pharmaceutical ETF 4.52
    View all Hepatitis C Virus Infection ETFs...
    Compare ETFs
    Compare PPH to MEDX Compare RDIV to MEDX Compare RDIV to PPH

        Hepatitis C Virus Infection Stocks Recent News

        Date Stock Title
        Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
        Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
        Oct 1 BMY BMS and Prime ink potential $3.5bn deal to develop T cell therapies
        Oct 1 IONS Ionis gets U.S. FDA fast track designation for its Alexander disease treatment
        Oct 1 BMY Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
        Oct 1 IONS Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
        Oct 1 BMY 5 FDA decisions to watch in the fourth quarter
        Oct 1 BMY Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
        Sep 30 BMY Bristol Myers gets $6.4B Celgene CVR case dismissed: report
        Sep 30 BMY Sector Update: Health Care Stocks Advance Late Afternoon
        Sep 30 BMY US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
        Sep 30 BMY Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
        Sep 30 BMY Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates
        Sep 30 BMY Bristol, Prime Medicine in deal to develop T-cell therapies
        Sep 30 BMY Company News for Sep 30, 2024
        Sep 30 BMY Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
        Sep 30 BMY Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
        Sep 30 BMY Prime to narrow gene editing research as it strikes deal with Bristol Myers
        Sep 28 BMY 3 Surprisingly Underrated Stocks to Buy Right Now
        Sep 28 BMY Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis
        Hepatitis C Virus Infection

        Hepatitis C virus (HCV) infection is a contagious liver disease caused by the hepatitis C virus. It is spread through contact with the blood of an infected person. Symptoms of HCV infection can range from mild to severe and may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored stools, joint pain, and jaundice. In some cases, HCV infection can lead to serious liver problems, including cirrhosis and liver cancer. Treatment for HCV infection typically involves a combination of antiviral medications.

        Browse All Tags